How To Use the NDAA Pages

Back to William M. (Mac) Thornberry NDAA Contents

TITLE VIII--ACQUISITION POLICY, ACQUISITION MANAGEMENT, AND RELATED MATTERS

Subtitle D--Industrial Base Matters

P. L. 116-

House Conference Report   116-617

(1) in subsection (b)(2)--

(A) in subparagraph (A)--

(i) in the matter preceding clause (i), by inserting ``such as those identified through the supply chain risk management process of the Department and by the Federal Acquisition Security Council, and'' after ``supply chain risks,''; and

(ii) in clause (ii), by striking ``(other than optical transmission components)'';

(B) in subparagraph (C)--

(i) in clause (x), by striking ``; and'' and inserting a semicolon;

(ii) by redesignating clause (xi) as clause (xii); and

(iii) by inserting after clause (x) the following new clause:

``(xi) processes and procedures related to supply chain risk management and processes and procedures implemented pursuant to section 2339a of this title; and''; and

(C) by adding at the end the following new subparagraph:

``(E) Characterization and assessment of industrial base support policies, programs, and procedures, including--

``(i) limitations and acquisition guidance relevant to the national technology and industrial base (as defined in section 2500(1) of this title);

``(ii) limitations and acquisition guidance relevant to section 2533a of this title;

``(iii) the Industrial Base Analysis and Sustainment program of the Department, including direct support and common design activities;

``(iv) the Small Business Innovation Research Program (as defined in section 9(e) of the Small Business Act (15 U.S.C. 638(e));

``(v) the Manufacturing Technology Program established under section 2521 of this title;

``(vi) programs relating to the Defense Production Act of 1950 (50 U.S.C. 4511 et seq.); and

``(vii) programs operating in each military department.''; and

(2) in subsection (f)(2), by inserting ``, and supporting policies, procedures, and guidance relating to such actions'' after ``subsection (b)''.

(b) Conforming Amendment.--Section 806 of the Ike Skelton National Defense Authorization Act for Fiscal Year 2011 (10 U.S.C. 2304 note) is repealed.

The House bill contained a provision (sec. 816) that would make a technical change related to optical transmission components.

The Senate amendment contained a similar provision (sec. 804) that would amend section 2509 of title 10, United States Code, to add references to matters of existing law, regulation, policy, and associated activities, and that would make a technical change related to optical transmission components.

The House recedes with a technical amendment regarding authorities originally established in section 806 of the Ike Skelton National Defense Authorization Act for Fiscal Year 2011 (Public Law 111-383) that were subsequently made permanent in section 881 of the John S. McCain National Defense Authorization Act for Fiscal Year 2019 (Public Law 115-232).

House Committee Report 116-442 Accompanying H. R. 6395

Section 816--Inclusion of Optical Transmission Components in the Analytical Framework for Supply Chain Risks

This section would amend section 2509(b)(2)(A)(ii) of title 10, United States Code, by striking the phrase ``(other than optical transmission components)''.

Senate Committee Report 116-236 to Accompanying S. 4049

Modification of framework for modernizing acquisition processes to ensure integrity of industrial base (sec. 804)

The committee recommends a provision that would amend section 2509 of title 10, United States Code, to add references to matters of existing law, regulation, policy, and associated activities and that would make a technical change related to optical transmission components. The committee appreciates the Department of Defense's continued attention to challenges that it faces in modernizing acquisition processes to ensure the integrity of the defense industrial base.

In carrying out the assessment required by section 2509 of title 10, United States Code, due March 15, 2022, the Comptroller General of the United States shall incorporate the following additional objectives: (1) The use by the Defense Logistics Agency and the Defense Health Agency of contracts for the purchase of drugs and medical devices; (2) The effect that increasing domestic manufacturing may have on the price and quality of drugs and medical devices used by the Department of Defense; and (3) The opportunities for investment in domestic advanced manufacturing capabilities for drugs and medical devices to reduce supply chain dependence risks to members of the Armed Forces and civilians.